Skip to content

Precision of navigational guidance for placing dental implants with the DENACAM system

Precision of navigational guidance for placing dental implants with the DENACAM system

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00030849
Enrollment
67
Registered
2022-12-13
Start date
2023-01-13
Completion date
Unknown
Last updated
2025-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

K08.1

Interventions

Group 1: Dynamic navigation of dental implant placement

Sponsors

Mininavident AG
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: • All ethnicities are considered • Partially dentate patients (mandible or maxilla) indicated for one or more dental implants with sufficient teeth in the arch to hold the tray (for marker fixation) registration. • Clinical situation suited for implantation as judged by the examining physician or principal investigator (satisfactory soft and hard tissue conditions and occlusion) • The patient must understand and sign the declaration of informed consent and be able to take part in the planned study program.

Exclusion criteria

Exclusion criteria: Patients with one or several of the following criteria cannot be included in the study: • Patients who are contraindicated generally for dental implant and/or study device • Patients who are not able to bear the risks of the procedure • Patients who are unable to understand and sign the declaration of informed consent • Patients currently taking part in another study for which the endpoints have not yet been reached • Patients suffering from a mental illness and/or who have been diagnosed with depression or are in a vulnerable population group (e.g., prisoners, serious drug addicts, persons with developmental problems) that hampers their ability to provide a declaration of informed consent.

Design outcomes

Primary

MeasureTime frame
(1a) Effectiveness: Mean deviation (real vs. planned) of largest angle from z-axis. Note 1: 1-sided test, experimental hypothesis: mean deviation < “free hand” performance goal. Note 2: The “free hand” performance is 3.5°, “free hand” performance goal is 3.9° Note 3: Since angles (and other distance measures) are right-skewed, the mean deviation will be estimated via back-transformation of mean of transformed values Note 4: square root transformation will be applied, but final decision on transformation will be made in statistical analysis plan. (1b) Safety: Proportion of patients with device related SAE (SADE) until discharge Note: the denominator is the number of patients in ITT analysis set. In addition, the number of patients in mITT is used as denominator.

Secondary

MeasureTime frame
(2) Mean deviation (real vs. planned) of deviation on apex in XY-direction (mesiodistal and oro-vestibular, 2D horizontal difference) Note 1: absolute values are used Note 2: 1-sided test, experimental hypothesis: mean deviation < “free hand” performance goal Note 3: the “free hand” performance is assumed as 2.3 mm, the “free hand” performance goal is 2.6 mm Notes 4, 5: see notes 3, 4 of primary performance endpoint (3) Mean deviation (real vs. planned) of deviation on basis (shoulder) in XY-direction (mesiodistal and oro-vestibular, 2D horizontal difference) Note 1: absolute values are used Note 2: 1-sided test, experimental hypothesis: mean deviation < “free hand” performance Note 3: the “free hand” performance is assumed as 1.2 mm, the “free hand” performance goal is 1.4 mm Notes 4, 5: see notes 3, 4 of primary performance endpoint Note 6: this endpoint is relevant for sample size estimation, because the difference of deviation between investigated method and “free hand” performance is expected to be the smallest.

Countries

Germany

Contacts

Public ContactStefan Röhling

Oralchirurgie T1

sr@oralchirurgie-t1.de+49 89 23 66 800

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026